Background
Ferroptosis is a newly defined form of iron dependent regulatory cell death distinct from apoptosis, autophagy, and necrosis, characterized by an abnormal increase in intracellular lipid reactive oxygen species. Diabetes nephropathy (DN) is one of the most common complications of diabetes and the most common cause of end-stage renal disease. Recent studies have shown that ferroptosis plays an important role in the occurrence and development of diabetic nephropathy. Swietenine belongs to the limonin class of compounds, which are extracted from the the Swietenia macrophylla King, a plant of the genus Swietenia, family Meliaceae King and have not been artificially synthesized to date. It is a natural product with a variety of pharmacological activities such as anti diabetes, improving inflammation, anti-oxidation, anti-bacterial, anti-tumor, etc. However, it is unclear whether Swietenine can improve diabetes nephropathy by inhibiting the occurrence of ferroptosis in glomerular podocytes (MPC-5) and its potential mechanism.
Objective
This study investigated the natural product Swi through Akt/GSK-3β/Nrf2 signaling pathway inhibits MPC-5 ferroptosis and improves diabetes nephropathy in the process of diabetes.
Method
In vivo, 8-week-old SD rats were induced with STZ/HFD to investigate the effect of Swi on improving DN and resisting ferroptosis. In vitro, the inhibitory effects of Swi on MPC-5 death. By giving verify the activation effect of Akt/GSK-3β/Nrf2 signaling pathway related inhibitors on downstream anti ferroptosis related proteins.
Results
In this study, Swi treatment improved renal injury in DN rats, which was proved by renal function related indexes, histopathological parameters and podocyte damage protein. In addition, Swi inhibited ferroptosis in vivo. Swi improved HG-induced MPC-5 cell viability, inhibited ferroptosis in MPC-5 cells. Swi inhibits ferroptosis by activating the Akt/GSK-3β/Nrf2 signaling pathway, which promotes the expression of downstream anti-ferroptosis related proteins.
Conclusion
Our research findings suggest for the first time that it may be through a new Akt/GSK-3β/Nrf2 dependent ferroptosis regulates the signaling pathway, thereby reducing the level of high glucose induced ferroptosis and improving diabetes nephropathy, which is expected to become a promising candidate drug for the treatment of diabetes